No Data
No Data
Wellnex Life Records AU$2 Million in Orders for April; Shares Jump 17%
Wellnex Life (ASX:WNX) posted AU$2 million of orders in April and a record of about AU$350,000 in operating profit, according to a Thursday Australian bourse filing. Gross margins for the January to A
Wellnex Life Expands Wakey Wakey Range With Two New Products
Wellnex Life (ASX:WNX) launched two new products under the Wakey Wakey brand, expanding the range to eight product lines, and increasing the company's presence in the health and pharmaceutical market,
Wellnex Life's Loss Widens in H1 FY24
Wellnex Life's (ASX:WNX) net loss attributable to shareholders widened by 131.5% to AU$9.8 million in the half-year ended Dec. 31, 2023, from AU$4.2 million a year ago, according to a Thursday filing
Wellnex Life's Paracetamol Soft Gel Liquid Analgesic Secures UK Regulatory Approval; Shares Climb 4%
Wellnex Life's (ASX:WNX) paracetamol soft gel liquid pain reliever, which was registered with the Therapeutic Goods Administration (TGA), obtained regulatory approval in the UK, allowing its sale in t
Wellnex Life to Release Shares From Escrow; Shares Rise 4%
Wellnex Life (ASX:WNX) is set to release 20,831,667 shares from escrow on Jan. 12, according to a Friday report. Shares of the consumer healthcare firm rose 4% in recent trade. Price (AUD): $0.03, Ch
Wellnex Signs International Distribution Agreement With Homart Pharmaceuticals
Wellnex Life (ASX:WNX) has signed an exclusive distribution agreement with Homart Pharmaceuticals to commence sales of all Wellnex brands in significant Asian markets. Having access to the Asian marke
No Data